RegenoGel - The next Generation treatment for Osteoarthritis
ProCore Ltd is a leading biotechnology company dedicated to developing innovative solutions that enhance the lives of patients affected by joint and bone diseases. With a strong focus on research and development, ProCore Ltd leverages its expertise to create cutting-edge treatments that promote natural healing and regeneration. The company's flagship RegenoGel family, built upon the proprietary HAProLink technology, exemplifies its commitment to biomimetic innovation.
ProCore Ltd's HAProLink technology platform links hyaluronic acid to a chosen protein, creating a unique microenvironment that encourages the body to gently regenerate cartilage and bone. RegenoGel products, already approved by Israel’s Ministry of Health and available since 2016, demonstrate the company's ability to translate scientific breakthroughs into commercially viable solutions. ProCore Ltd is located at 7 Golda Meir St., Ness Ziona, IL.
ProCore Ltd is positioned for continued growth and success in the biotechnology sector. We invite the management of ProCore Ltd to create a customized and exclusive company showcase and product listing on our platform to further amplify their market presence and commercial development.
Other organizations in the same industry
This company is also known as